Burning Rock Biotech Ltd ADR (BNR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Cash Flows From Operating Activities | |||||
| Net Income | N/A | N/A | N/A | -47,489 | N/A |
| Depreciation Amortization | N/A | N/A | N/A | 7,151 | N/A |
| Accounts receivable | N/A | N/A | N/A | -4,470 | N/A |
| Accounts payable and accrued liabilities | N/A | N/A | N/A | 2,588 | N/A |
| Other Working Capital | N/A | N/A | N/A | -5,004 | N/A |
| Other Operating Activity | -7,232 | -9,475 | -3,242 | 34,584 | -15,863 |
| Operating Cash Flow | $-7,232 | $-9,475 | $-3,242 | $-12,640 | $-15,863 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | N/A | N/A | -528 | N/A |
| Purchase Sale Intangibles | N/A | N/A | N/A | -76 | N/A |
| Other Investing Activity | -572 | -185 | -211 | -76 | -513 |
| Investing Cash Flow | $-572 | $-185 | $-211 | $-604 | $-513 |
| Cash Flows From Financing Activities | |||||
| Common Stock Repurchased | N/A | N/A | N/A | -10 | N/A |
| Other Financing Activity | 281 | 279 | 0 | 0 | 0 |
| Financing Cash Flow | $281 | $279 | $N/A | $-10 | $N/A |
| Exchange Rate Effect | -229 | 8 | 43 | 506 | -292 |
| Beginning Cash Position | 73,348 | 72,891 | 71,955 | 84,284 | 87,668 |
| End Cash Position | 65,596 | 63,518 | 68,545 | 71,536 | 71,000 |
| Net Cash Flow | $-7,752 | $-9,373 | $-3,410 | $-12,748 | $-16,668 |
| Free Cash Flow | |||||
| Operating Cash Flow | -7,232 | -9,475 | -3,242 | -12,640 | -15,863 |
| Capital Expenditure | N/A | N/A | N/A | -742 | N/A |
| Free Cash Flow | -7,232 | -9,475 | -3,242 | -13,382 | -15,863 |